CABG Still Superior to Stents Despite FAME 3 Endpoint Swap

Bypass surgery trumped stents in multivessel disease in prior trials and FAME 3 at 1 year. But a change in endpoint at 3 and 5 years pushed stents ahead. It’s not right, says John Mandrola, MD.

Read the full article here

Related Articles